Merck
MRK
#73
Rank
$198.52 B
Marketcap
$79.06
Share price
-0.29%
Change (1 day)
-39.03%
Change (1 year)

Merck (MRK) - P/B ratio

P/B ratio as of June 2025 : 4.12

According to Merck's latest financial reports the company has a price-to-book ratio of 3.12298.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Merck - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-315.44-25.91%
2023-12-317.3420.19%
2022-12-316.1120.7%
2021-12-315.06-37.89%
2020-12-318.15-8.27%
2019-12-318.8820.52%
2018-12-317.3766.17%
2017-12-314.4310.13%
2016-12-314.0322.72%
2015-12-313.28-0.67%
2014-12-313.3017.97%
2013-12-312.8025.34%
2012-12-312.2310.71%
2011-12-312.023.2%
2010-12-311.965.86%
2009-12-311.85-39.16%
2008-12-313.04-50.47%
2007-12-316.1329.51%
2006-12-314.7339.03%
2005-12-313.40-5.53%
2004-12-313.60-31.56%
2003-12-315.27-4.43%
2002-12-315.51

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.50-63.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
4.61 11.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
43.4 951.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.47 32.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.44-65.11%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
4.38 6.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
3.16-23.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
5.96 44.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
4.71 14.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
25.2 510.61%๐Ÿ‡บ๐Ÿ‡ธ USA